Fridays vs Push Health

Neither Fridays nor Push Health has an FDA warning letter on record. Push Health publishes no GLP-1 price we could capture. Fridays starts at $249 a month for compounded semaglutide injection.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Push Health

Fridays logo

Fridays

5.8/10

Push Health logo

Push Health

4.1/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
No GLP-1 price published
States
No state list published
No state list published
Checked
Prices captured Record checked October 2026
Prices captured Record checked September 2026

Neither Fridays nor Push Health pays us. Links to them earn nothing. Scores: Fridays 5.8, Push Health 4.1. How we are paid

What the record shows

  1. 01

    Neither Fridays nor Push Health has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Push Health names no compounding pharmacy in our record.

  3. 03

    Push Health publishes no GLP-1 price we could capture. Fridays starts at $249 a month for compounded semaglutide injection.

  4. 04

    Only Fridays lists a price for compounded semaglutide injection, compounded tirzepatide injection and brand-name semaglutide pen.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Push Health

Compounded semaglutide injection

$249/mo

$2,988 a year

Not sold or not priced
Compounded tirzepatide injection

$359/mo

$4,308 a year

Not sold or not priced
Brand-name semaglutide pen

$1,498/mo

$17,976 a year

Not sold or not priced
Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
None
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
Full refund if you cancel before the provider writes a prescription; none after

Read off each seller’s own pages. Fridays: October 30, 2026. Push Health: September 28, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells compounded semaglutide injection and compounded tirzepatide injection, which Push Health does not price

The case for Push Health

4.1/10

The record gives Push Health no edge on this pair.

  • Names no compounding pharmacy
  • Publishes no GLP-1 price

Scores

Fridays 5.8 · Push Health 4.1 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
5.0

User Experience15%

3.0A
vs
B
3.0

Trust & Safety15%

5.5A
vs
B
4.0

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Push Health: questions

Neither Fridays nor Push Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Push Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Push Health states you can cancel at any time; refunds: full refund if you cancel before the provider writes a prescription; none after.
Neither Fridays nor Push Health pays us. Links to them earn nothing. Scores: Fridays 5.8, Push Health 4.1.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks